Community-acquired legionella pneumophila pneumonia: A single-center experience with 214 hospitalized sporadic cases over 15 years

Medicine (United States)

Volumn 92, Issue 1, 2013, Pages 51-60

  Viasus, Diego ^a   Di Yacovo, Silvana ^a   Garcia Vidal, Carolina ^a   Verdaguer, Ricard ^a   Manresa, Frederic ^a,b   Dorca, Jordi ^a,b   Gudiol, Francesc ^a,b   Carratalà, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; ROXITHROMYCIN;

ADULT; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DIABETES MELLITUS; FATALITY; FEMALE; HEART DISEASE; HOSPITAL ADMINISTRATOR; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; SEROCONVERSION; SMOKING; THORAX PAIN;

AGED; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 84871926538     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31827f6104     Document Type: Article

References (41)

1. Benin AL, Benson RF, Besser RE. Trends in Legionnaires disease,1980Y1998: declining mortality and new patterns of diagnosis.Clin Infect Dis. 2002;35:1039-1046. (Pubitemid 35239462)
2. Blazquez Garrido RM, Espinosa Parra FJ, Alemany Frances L, RamosGuevara RM, Sanchez-Nieto JM, Segovia Hernandez M, SerranoMartinez JA, Huerta FH. Antimicrobial chemotherapy for Legionnairesdisease: levofloxacin versus macrolides. Clin Infect Dis. 2005;40:800-806. (Pubitemid 40365497)
3. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA,Schein RM, Sibbald WJ. Definitions for sepsis and organ failure andguidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of ChestPhysicians/Society of Critical Care Medicine. Chest.1992;101:1644-1655.
4. Carratala J, Garcia-Vidal C. An update on Legionella. Curr Opin InfectDis. 2010;23:152-157.
5. Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrus A,Mensa J, Torres A. Microbial aetiology of community-acquiredpneumonia and its relation to severity. Thorax. 2011;66:340-346.
6. Darby J, Buising K. Could it be Legionella? Aust Fam Physician.2008;37: 812-815.
7. den Boer JW, Yzerman EP, Jansen R, Bruin JP, Verhoef LP, Neve G,van der Zwaluw K. Legionnaires'disease and gardening. Clin MicrobiolInfect. 2007;13:88-91.
8. Diaz A, Barria P, Niederman M, Restrepo MI, Dreyse J, Fuentes G,Couble B, Saldias F. Etiology of community-acquired pneumonia inhospitalized patients in Chile: the increasing prevalence of respiratoryviruses among classic pathogens. Chest. 2007;131:779-787. (Pubitemid 46446870)
9. Falco V, Molina I, Juste C, Crespo M, Almirante B, Pigrau C, Ferrer A,Bravo C, Palomar M, Pahissa A. ETreatment for Legionnaires' disease.Macrolides or quinolones? Enferm Infecc Microbiol Clin.2006;24:360-364.
10. Fernandez-Sabe N, Roson B, Carratala J, Dorca J, Manresa F, Gudiol F.Clinical diagnosis of Legionella pneumonia revisited: evaluation ofthe Community-Based Pneumonia Incidence Study Group scoringsystem. Clin Infect Dis. 2003;37:483-489. (Pubitemid 37011770)
11. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE,Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identifylow-risk patients with community-acquired pneumonia. N Engl J Med.1997;336:243-250. (Pubitemid 27044625)
12. Garcia-Vidal C, Carratala J. Current clinical management ofLegionnaires' disease. Expert Rev Anti Infect Ther. 2006;4:995-1004. (Pubitemid 46043020)
13. Gupta SK, Imperiale TF, Sarosi GA. Evaluation of theWinthrop-University Hospital criteria to identify Legionellapneumonia. Chest. 2001;120:1064-1071. (Pubitemid 32960073)
14. Guyard C, Low DE. Legionella infections and travel associatedlegionellosis. Travel Med Infect Dis. 2011;9:176-186.
15. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS,Singer DE. Time to clinical stability in patients hospitalized withcommunity-acquired pneumonia: implications for practice guidelines.JAMA. 1998;279:1452-1457. (Pubitemid 28228202)
16. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. Legionellapneumonia in cancer patients. Medicine (Baltimore). 2008;87:152-159.
17. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J.Etiology of community-acquired pneumonia: increased microbiologicalyield with new diagnostic methods. Clin Infect Dis. 2010;50:202-209.
18. Joseph CA, Ricketts KD; European Working Group for LegionellaInfections. Legionnaires disease in Europe 2007Y2008. Euro Surveill.2010;15:19493.
19. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, LeinonenM, Saikku P. Study of Community Acquired Pneumonia Aetiology(SCAPA) in adults admitted to hospital: implications for managementguidelines. Thorax. 2001;56:296-301. (Pubitemid 32269810)
20. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD,Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, TorresA, Whitney CG. Infectious Disease Society of America/AmericanThoracic Society consensus guidelines on the management ofcommunity-acquired pneumonia in adults. Clin Infect Dis.2007;44(Suppl 2):S27YS72.
21. Mulazimoglu L, Yu VL. Can Legionnaires disease be diagnosedby clinical criteria? A critical review. Chest. 2001;120:1049-1053. (Pubitemid 32960067)
22. Mykietiuk A, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R,Manresa F, Gudiol F. Clinical outcomes for hospitalized patients withLegionella pneumonia in the antigenuria era: the influence oflevofloxacin therapy. Clin Infect Dis. 2005;40:794-799. (Pubitemid 40365496)
23. Neil K, Berkelman R. Increasing incidence of legionellosis in theUnited States, 1990-2005: changing epidemiologic trends. Clin InfectDis. 2008;47:591-599.
24. Newton HJ, Ang DK, van Driel IR, Hartland EL. Molecularpathogenesis of infections caused by Legionella pneumophila.Clin Microbiol Rev. 2010;23:274-298.
25. Ng V, Tang P, Fisman DN. Our evolving understanding of legionellosisepidemiology: learning to count. Clin Infect Dis. 2008;47:600-602.
26. Ng V, Tang P, Jamieson F, Guyard C, Low DE, Fisman DN.Laboratory-based evaluation of legionellosis epidemiology inOntario, Canada, 1978 to 2006. BMC Infect Dis. 2009;9:68.
27. Ngeow YF, Suwanjutha S, Chantarojanasriri T, Wang F, Saniel M,Alejandria M, Hsueh PR, Ping-Ing L, Park SC, Sohn JW, Aziah AM, LiuY, Seto WH, Ngan CC, Hadiarto M, Hood A, Cheong YM. An Asianstudy on the prevalence of atypical respiratory pathogens incommunity-acquired pneumonia. Int J Infect Dis. 2005;9:144-153. (Pubitemid 40523759)
28. Pedro-Botet ML, Garcia-Cruz A, Tural C, Mateu L, Sopena N, Roure S,Rey-Joly C, Sabria M. Severe Legionnaires'disease successfully treatedwith levofloxacin and azithromycin. J Chemother. 2006;18:559-561.
29. Pedro-Botet L, Yu VL. Legionella: macrolides or quinolones? ClinMicrobiol Infect. 2006;12(Suppl 3):25-30.
30. Plouffe JF, Breiman RF, Fields BS, Herbert M, Inverso J, Knirsch C,Kolokathis A, Marrie TJ, Nicolle L, Schwartz DB. Azithromycin in thetreatment of Legionella pneumonia requiring hospitalization. Clin InfectDis. 2003;37:1475-1480. (Pubitemid 37494675)
31. Rello J, Bodi M, Mariscal D, Navarro M, Diaz E, Gallego M, Valles J.Microbiological testing and outcome of patients with severecommunity-acquired pneumonia. Chest. 2003;123:174-180. (Pubitemid 36126730)
32. Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F.Causes and factors associated with early failure in hospitalized patientswith community-acquired pneumonia. Arch Intern Med. 2004;164:502-508. (Pubitemid 38314445)
33. Sabria M, Pedro-Botet ML, Gomez J, Roig J, Vilaseca B, Sopena N,Banos V; Legionnaires Disease Therapy Group. Fluoroquinolones vsmacrolides in the treatment of Legionnaires disease. Chest.2005;128:1401-1405. (Pubitemid 41324424)
34. Singanayagam A, Chalmers JD, Hill AT. Severity assessment incommunity-acquired pneumonia: a review. QJM. 2009;102:379-388.
35. Sohn JW, Park SC, Choi YH, Woo HJ, Cho YK, Lee JS, Sim HS, KimMJ. Atypical pathogens as etiologic agents in hospitalized patients withcommunity-acquired pneumonia in Korea: a prospective multi-centerstudy. J Korean Med Sci. 2006;21:602-607.
36. Sopena N, Sabria M, Pedro-Botet ML, Manterola JM, Matas L,Dominguez J, Modol JM, Tudela P, Ausina V, Foz M. Prospective studyof community-acquired pneumonia of bacterial etiology in adults.Eur J Clin Microbiol Infect Dis. 1999;18:852-858. (Pubitemid 30066162)
37. Vergis EN, Akbas E, Yu VL. Legionella as a cause of severe pneumonia.Semin Respir Crit Care Med. 2000;21:295-304. (Pubitemid 30661096)
38. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA,Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime pluserythromycin for empirical treatment of community-acquiredpneumonia in hospitalized patients: a prospective, randomized,multicenter trial. Arch Intern Med. 2000;160:1294-1300. (Pubitemid 30252775)
39. von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, LuckC; Competence Network for Community Acquired Pneumonia StudyGroup. Community-acquired Legionella pneumonia: new insights fromthe German Competence Network for Community-AcquiredPneumonia. Clin Infect Dis. 2008;46:1356-1364. (Pubitemid 351589933)
40. Whiley H, Bentham R. Legionella longbeachae and legionellosis.Emerg Infect Dis. 2011;17:579-583.
41. Yu VL, Stout JE. Community-acquired legionnaires disease:implications for underdiagnosis and laboratory testing. Clin Infect Dis.2008;46:1365-1367. (Pubitemid 351589934)